prikaz prve stranice dokumenta Određivanje fenotipa raka dojke imunohistokemijskim bojanjem.
  Download
PDF 1001.56 KB
undergraduate thesis
Određivanje fenotipa raka dojke imunohistokemijskim bojanjem.
2017. urn:nbn:hr:152:587177
Jelenić, Jelena
Josip Juraj Strossmayer University of Osijek
Faculty of Medicine Osijek

Cite this document

Jelenić, J. (2017). Određivanje fenotipa raka dojke imunohistokemijskim bojanjem. (Undergraduate thesis). Osijek: Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek. Retrieved from https://urn.nsk.hr/urn:nbn:hr:152:587177

Jelenić, Jelena. "Određivanje fenotipa raka dojke imunohistokemijskim bojanjem.." Undergraduate thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek, 2017. https://urn.nsk.hr/urn:nbn:hr:152:587177

Jelenić, Jelena. "Određivanje fenotipa raka dojke imunohistokemijskim bojanjem.." Undergraduate thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek, 2017. https://urn.nsk.hr/urn:nbn:hr:152:587177

Jelenić, J. (2017). 'Određivanje fenotipa raka dojke imunohistokemijskim bojanjem.', Undergraduate thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek, accessed 02 April 2025, https://urn.nsk.hr/urn:nbn:hr:152:587177

Jelenić J. Određivanje fenotipa raka dojke imunohistokemijskim bojanjem. [Undergraduate thesis]. Osijek: Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek; 2017 [cited 2025 April 02] Available at: https://urn.nsk.hr/urn:nbn:hr:152:587177

J. Jelenić, "Određivanje fenotipa raka dojke imunohistokemijskim bojanjem.", Undergraduate thesis, Josip Juraj Strossmayer University of Osijek, Faculty of Medicine Osijek, Osijek, 2017. Available at: https://urn.nsk.hr/urn:nbn:hr:152:587177

Please login to the repository to save this object to your list.
Metadata
TitleOdređivanje fenotipa raka dojke imunohistokemijskim bojanjem.
Title (english)Assessment of breast cancer phenotype by immunohistochemistry.
AuthorJelena Jelenić
MentorKsenija Marjanović (mentor)
Committee memberMilanka Mrčela (predsjednik povjerenstva)
Committee memberBranka Lončar (član povjerenstva)
Committee memberKsenija Marjanović (član povjerenstva)
GranterJosip Juraj Strossmayer University of Osijek
Faculty of Medicine Osijek
Osijek
Defense date and country2017-09-27, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Pathology
Abstract
CILJ ISTRAŽIVANJA. Utvrditi broj dijagnosticiranih karcinoma dojke u dvogodišnjem razdoblju, utvrditi učestalost karcinoma dojke prema fenotipu te usporediti zastupljenost pojedinih histoloških tipova u odnosu na fenotip karcinoma dojke. USTROJ STUDIJE. Retrospektivna poredbena studija. ISPITANICI I METODE. Studijom je obuhvaćeno 363 novo otkrivenih duktalnih in situ karcinoma dojke (DCIS) i invazivnih karcinoma dojke dijagnosticiranih na Zavodu za patologiju i sudsku medicinu KBC-a Osijek.... More Kod svih dijagnosticiranih karcinoma, imunohistokemijski su određeni estrogeni i progesteronski receptori, HER2 antigen i Ki67 proliferacijski indeks. Za imunohistokemijsku obradu tkiva koristio se automatski bojač Ventana Benchmark Ultra tvrtke Roche i monoklonalna primarna antitijela tvrtke Roche namijenjena za laboratorijsku uporabu. REZULTATI. U razdoblju od 1. siječnja 2015. godine do 31. prosinca 2016. godine na Zavodu za patologiju i sudsku medicinu KBC-a Osijek dijagnosticirano je 342 invazivnih karcinoma dojke. Najveći broj ispitanika bio je u dobnim skupinama od 60 do 69 godina (31,58 %), s prosječnom životnom dobi od 61,6 godina. Najzastupljeniji invazivni karcinomi dojke prema histološkome tipu su bili duktalni invazivni karcinomi (87,43 %), a prema fenotipu luminal B HER negativnoga fenotipa (48,54 %). Duktalni (48,16 %) i lobularni (52,94 %) invazivni karcinomi dojke te miješani (75 %) karcinomi bili su najčešće luminal B HER negativnoga tipa. Medularni karcinomi (75 %) većinom su bili trostruko negativnoga fenotipa, kao i mucinozni karcinom. ZAKLJUČAK. U dijagnostici invazivnih karcinoma dojke neophodna je imunohistokemijska obrada tkiva karcinoma radi određivanja točnoga fenotipa karcinoma s ciljem određivanja prikladne terapije. Less
Abstract (english)
OBJECTIVES. To determine a number of diagnosed breast carcinomas in a two-year period. To determine a frequency of breast carcinomas according to a phenotype. To compare the presence of certain histological types with reference to the phenotype of breast carcinomas. STUDY DESIGN. A retrospective comparative study. PARTICIPANTS AND METHODS. The study includes 363 newly discovered ductal in situ breast carcinomas (DCIS) and invasive breast carcinomas diagnosed at the Clinical Institute for... More Pathology and Forensic Medicine at the Clinical Hospital Centre Osijek. By applying the method of immunohistochemistry, estrogen, progesterone, HER-2/neu and Ki-67 were determined. In order to immunohistochemically process tissues, the automatic counter Ventana BenchMark Ultra, produced by the company Roche, and monoclonal primal antibodies of the company Roche, made for the laboratory use, were used. RESULTS. In the period from January 2015 until December 2016, 342 invasive breast carcinomas were diagnosed at the Clinical Institute for Pathology and Forensic Medicine at the Clinical Hospital Centre Osijek. The majority of the examinees were at the age of 60 to 90 (31.58%) with the average age of 61.6 years. According to the histological type, the most frequent invasive breast carcinomas were ductal invasive carcinomas (87.43%). Furthermore, according to the phenotype, the most frequent was luminal B HER negative phenotype (48.54%). Ductal (48.16%) and lobular (52.94%) invasive breast carcinomas and mixed (75%) carcinomas were frequently luminal B of the negative type. Medullary carcinomas (75%) as well as mucinous carcinoma were mostly of the triple negative phenotype. CONCLUSION. In order to diagnose invasive breast carcinomas, the immunohistochemical treatment of a tissue is indispensable. It aims to determine the exact phenotype of carcinomas consequently determining the adequate therapy. Less
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:152:587177
Study programmeTitle: University undergraduate study
Study programme type: university
Study level: undergraduate
Academic / professional title: sveučilišni prvostupnik/prvostupnica (baccalaureus/ baccalaurea) medicinske laboratorijske dijagnostike (sveučilišni prvostupnik/prvostupnica (baccalaureus/ baccalaurea) medicinske laboratorijske dijagnostike)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2018-04-24 10:40:56
accessibility

closeAccessibilityrefresh

If you wish to permanently save changes, click on Save, if not - your settings will be reset when you restart the browser.